Use of strontium chloride for the treatment of osteoporosis

A case report

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Context • Strontium ranelate is an approved prescription medication for the treatment of osteoporosis in Europe. In the United States, the only available forms of strontium are those that are nonprescription, dietary supplements. Some patients with osteoporosis use those products because they prefer an alternate treatment to conventional therapy. Currently, no controlled trials have been conducted on the effectiveness of the supplements for treating osteoporosis. Objective • The study intended to examine how one woman responded to the use of strontium chloride. Design • This was a retrospective case study. Setting • The woman in the case study was a patient in an academic urban women’s health clinic in Minneapolis, MN, USA. Participant • The participant was a postmenopausal woman with a history of vertebral fracture. Intervention • The participant took 680 mg daily of strontium chloride for 2.5 y. Outcome Measures • The patient had begun receiving dual-energy X-ray absorptiometry (DXA) scans in 2004 and continued to receive follow-up scans every 2 y. After beginning strontium therapy in December 2011, she received DXA scans in March 2012 and May 2014. Results • During the study, the analysis of the patient’s DXA scans showed a positive increase in the bone mineral density (BMD) of her vertebrae and her right hip and maintenance of her BMD in her left hip. Conclusions • Although the current case report does not provide enough evidence to conclude that US dietary supplements of strontium are effective in preventing fractures, it demonstrates a positive experience for one patient.

Original languageEnglish (US)
Pages (from-to)66-70
Number of pages5
JournalAlternative Therapies in Health and Medicine
Volume22
Issue number3
StatePublished - May 1 2016

Fingerprint

Osteoporosis
Strontium
Photon Absorptiometry
strontium ranelate
Dietary Supplements
Bone Density
Pelvic Bones
Urban Health
Therapeutics
Women's Health
Prescriptions
Hip
Spine
Retrospective Studies
Maintenance
Outcome Assessment (Health Care)
strontium chloride

Cite this

Use of strontium chloride for the treatment of osteoporosis : A case report. / Westberg, Sarah M; Awker, Amy; Torkelson, Carolyn J.

In: Alternative Therapies in Health and Medicine, Vol. 22, No. 3, 01.05.2016, p. 66-70.

Research output: Contribution to journalArticle

@article{26ea46ebfd964b4b865ef9843b65da4a,
title = "Use of strontium chloride for the treatment of osteoporosis: A case report",
abstract = "Context • Strontium ranelate is an approved prescription medication for the treatment of osteoporosis in Europe. In the United States, the only available forms of strontium are those that are nonprescription, dietary supplements. Some patients with osteoporosis use those products because they prefer an alternate treatment to conventional therapy. Currently, no controlled trials have been conducted on the effectiveness of the supplements for treating osteoporosis. Objective • The study intended to examine how one woman responded to the use of strontium chloride. Design • This was a retrospective case study. Setting • The woman in the case study was a patient in an academic urban women’s health clinic in Minneapolis, MN, USA. Participant • The participant was a postmenopausal woman with a history of vertebral fracture. Intervention • The participant took 680 mg daily of strontium chloride for 2.5 y. Outcome Measures • The patient had begun receiving dual-energy X-ray absorptiometry (DXA) scans in 2004 and continued to receive follow-up scans every 2 y. After beginning strontium therapy in December 2011, she received DXA scans in March 2012 and May 2014. Results • During the study, the analysis of the patient’s DXA scans showed a positive increase in the bone mineral density (BMD) of her vertebrae and her right hip and maintenance of her BMD in her left hip. Conclusions • Although the current case report does not provide enough evidence to conclude that US dietary supplements of strontium are effective in preventing fractures, it demonstrates a positive experience for one patient.",
author = "Westberg, {Sarah M} and Amy Awker and Torkelson, {Carolyn J}",
year = "2016",
month = "5",
day = "1",
language = "English (US)",
volume = "22",
pages = "66--70",
journal = "Alternative Therapies in Health and Medicine",
issn = "1078-6791",
publisher = "InnoVision Communications",
number = "3",

}

TY - JOUR

T1 - Use of strontium chloride for the treatment of osteoporosis

T2 - A case report

AU - Westberg, Sarah M

AU - Awker, Amy

AU - Torkelson, Carolyn J

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Context • Strontium ranelate is an approved prescription medication for the treatment of osteoporosis in Europe. In the United States, the only available forms of strontium are those that are nonprescription, dietary supplements. Some patients with osteoporosis use those products because they prefer an alternate treatment to conventional therapy. Currently, no controlled trials have been conducted on the effectiveness of the supplements for treating osteoporosis. Objective • The study intended to examine how one woman responded to the use of strontium chloride. Design • This was a retrospective case study. Setting • The woman in the case study was a patient in an academic urban women’s health clinic in Minneapolis, MN, USA. Participant • The participant was a postmenopausal woman with a history of vertebral fracture. Intervention • The participant took 680 mg daily of strontium chloride for 2.5 y. Outcome Measures • The patient had begun receiving dual-energy X-ray absorptiometry (DXA) scans in 2004 and continued to receive follow-up scans every 2 y. After beginning strontium therapy in December 2011, she received DXA scans in March 2012 and May 2014. Results • During the study, the analysis of the patient’s DXA scans showed a positive increase in the bone mineral density (BMD) of her vertebrae and her right hip and maintenance of her BMD in her left hip. Conclusions • Although the current case report does not provide enough evidence to conclude that US dietary supplements of strontium are effective in preventing fractures, it demonstrates a positive experience for one patient.

AB - Context • Strontium ranelate is an approved prescription medication for the treatment of osteoporosis in Europe. In the United States, the only available forms of strontium are those that are nonprescription, dietary supplements. Some patients with osteoporosis use those products because they prefer an alternate treatment to conventional therapy. Currently, no controlled trials have been conducted on the effectiveness of the supplements for treating osteoporosis. Objective • The study intended to examine how one woman responded to the use of strontium chloride. Design • This was a retrospective case study. Setting • The woman in the case study was a patient in an academic urban women’s health clinic in Minneapolis, MN, USA. Participant • The participant was a postmenopausal woman with a history of vertebral fracture. Intervention • The participant took 680 mg daily of strontium chloride for 2.5 y. Outcome Measures • The patient had begun receiving dual-energy X-ray absorptiometry (DXA) scans in 2004 and continued to receive follow-up scans every 2 y. After beginning strontium therapy in December 2011, she received DXA scans in March 2012 and May 2014. Results • During the study, the analysis of the patient’s DXA scans showed a positive increase in the bone mineral density (BMD) of her vertebrae and her right hip and maintenance of her BMD in her left hip. Conclusions • Although the current case report does not provide enough evidence to conclude that US dietary supplements of strontium are effective in preventing fractures, it demonstrates a positive experience for one patient.

UR - http://www.scopus.com/inward/record.url?scp=84970028878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84970028878&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 66

EP - 70

JO - Alternative Therapies in Health and Medicine

JF - Alternative Therapies in Health and Medicine

SN - 1078-6791

IS - 3

ER -